18 results
Esophageal Crohn's Disease Management Algorithm

Assess for Active Symptoms and for Stricturing/Fistulizing Disease
Stricturing DX:
 • Bx r/o
Crohn's Disease Management ... for Active Symptoms ... DX: • Bx r/o Malignancy ... Crohns #Disease #Management ... #IBD
Fatigue and IBD Algorithm
 • 40-50% patients have fatigue despite clinical remission
 • Risk factors: BMI,
fatigue despite clinical ... NRH & Heme eval. re ... ileal Crohn's/resection ... /other causes • ... #management
Pulmonary Nodule
Evaluation is guided by nodule size & assessment of probability of malignancy. In addition is
probability of malignancy ... called lung masses ... , clinical judgment ... Management options ... , and surgical resection
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... known or suspected malignant ... Official ATS/STS/STR Clinical ... Effusions #MPE #Algorithm ... #Management #ATS
Rhabdomyolysis - Differential Diagnosis Framework and Management Summary

Causes of Rhabdomyolysis:
 • Trauma:
	- Immobilization
	- Crush injury
	- Compartment
Framework and Management ... Summary Causes ... - Seizures - Malignant ... - Neuroleptic malignant ... Dermatomyositis Clinical
Pott's Disease in Tuberculosis - Diagnosis and Management Summary
Epidemiology:
 - Typically from TB endemic areas
 -
extrapulmonary cases ... Clinical Signs ... signs/symptoms of active ... pulmonary TB PE ... excisional biopsy - Detection
Acromegaly - Diagnosis and Management Summary - GrepMed Handbook 

Clinical Presentation: 
 • Classic Acromegaly: frontal
Diagnosis and Management ... GrepMed Handbook Clinical ... colon (↑polyps & malignancy ... to CVD & colon malignancy ... or refractory cases
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
exclude other causes ... Clinical • Under-recognized ... sx: dyspnea on exertion ... Avoid ARBs • ICD ... support for patients clinically
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
terminal alveoli and are ... inhibitors • Injection ... characteristic features Clinical ... tracheobronchial stenosis, malignancy ... TB #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
terminal alveoli and are ... inhibitors • Injection ... characteristic features Clinical ... tracheobronchial stenosis, malignancy ... TB #Diagnosis #Management